906 related articles for article (PubMed ID: 11209967)
21. Visualization of HTLV-1-specific cytotoxic T lymphocytes in the spinal cords of patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
Matsuura E; Kubota R; Tanaka Y; Takashima H; Izumo S
J Neuropathol Exp Neurol; 2015 Jan; 74(1):2-14. PubMed ID: 25470342
[TBL] [Abstract][Full Text] [Related]
22. Mediators of central nervous system damage during the progression of human T-cell leukemia type I-associated myelopathy/tropical spastic paraparesis.
Barmak K; Harhaj EW; Wigdahl B
J Neurovirol; 2003 Oct; 9(5):522-9. PubMed ID: 13129766
[TBL] [Abstract][Full Text] [Related]
23. Detection of human T lymphotrophic virus type I (HTLV-I) proviral DNA and analysis of T cell receptor V beta CDR3 sequences in spinal cord lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis.
Hara H; Morita M; Iwaki T; Hatae T; Itoyama Y; Kitamoto T; Akizuki S; Goto I; Watanabe T
J Exp Med; 1994 Sep; 180(3):831-9. PubMed ID: 8064235
[TBL] [Abstract][Full Text] [Related]
24. Mogamulizumab, an anti-CCR4 antibody, targets human T-lymphotropic virus type 1-infected CD8+ and CD4+ T cells to treat associated myelopathy.
Yamauchi J; Coler-Reilly A; Sato T; Araya N; Yagishita N; Ando H; Kunitomo Y; Takahashi K; Tanaka Y; Shibagaki Y; Nishioka K; Nakajima T; Hasegawa Y; Utsunomiya A; Kimura K; Yamano Y
J Infect Dis; 2015 Jan; 211(2):238-48. PubMed ID: 25104771
[TBL] [Abstract][Full Text] [Related]
25. HTLV-I specific IFN-gamma+ CD8+ lymphocytes correlate with the proviral load in peripheral blood of infected individuals.
Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
J Neuroimmunol; 2000 Jan; 102(2):208-15. PubMed ID: 10636490
[TBL] [Abstract][Full Text] [Related]
26. Human T cell lymphotropic virus type I (HTLV-I)-specific CD4+ T cells: immunodominance hierarchy and preferential infection with HTLV-I.
Goon PK; Igakura T; Hanon E; Mosley AJ; Barfield A; Barnard AL; Kaftantzi L; Tanaka Y; Taylor GP; Weber JN; Bangham CR
J Immunol; 2004 Feb; 172(3):1735-43. PubMed ID: 14734756
[TBL] [Abstract][Full Text] [Related]
27. Temporal lesions and widespread involvement of white matter associated with multi-organ inflammatory disease in human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Mendes GB; Kalil RS; Rosadas C; de Freitas MR; Puccioni-Sohler M
Int J Infect Dis; 2014 Aug; 25():1-3. PubMed ID: 24815740
[TBL] [Abstract][Full Text] [Related]
28. The effect of HTLV-1 virulence factors (HBZ, Tax, proviral load), HLA class I and plasma neopterin on manifestation of HTLV-1 associated myelopathy tropical spastic paraparesis.
Tarokhian H; Taghadosi M; Rafatpanah H; Rajaei T; Azarpazhooh MR; Valizadeh N; Rezaee SAR
Virus Res; 2017 Jan; 228():1-6. PubMed ID: 27845163
[TBL] [Abstract][Full Text] [Related]
29. Programmed death-1 (PD-1)/PD-1 ligand pathway-mediated immune responses against human T-lymphotropic virus type 1 (HTLV-1) in HTLV-1-associated myelopathy/tropical spastic paraparesis and carriers with autoimmune disorders.
Kozako T; Yoshimitsu M; Akimoto M; White Y; Matsushita K; Soeda S; Shimeno H; Kubota R; Izumo S; Arima N
Hum Immunol; 2011 Nov; 72(11):1001-6. PubMed ID: 21851845
[TBL] [Abstract][Full Text] [Related]
30. Multistability in a model for CTL response to HTLV-I infection and its implications to HAM/TSP development and prevention.
Gómez-Acevedo H; Li MY; Jacobson S
Bull Math Biol; 2010 Apr; 72(3):681-96. PubMed ID: 20041353
[TBL] [Abstract][Full Text] [Related]
31. Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
Baratella M; Forlani G; Raval GU; Tedeschi A; Gout O; Gessain A; Tosi G; Accolla RS
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005285. PubMed ID: 28095504
[TBL] [Abstract][Full Text] [Related]
32. High human T cell lymphotropic virus type 1 (HTLV-1)-specific precursor cytotoxic T lymphocyte frequencies in patients with HTLV-1-associated neurological disease.
Elovaara I; Koenig S; Brewah AY; Woods RM; Lehky T; Jacobson S
J Exp Med; 1993 Jun; 177(6):1567-73. PubMed ID: 8496677
[TBL] [Abstract][Full Text] [Related]
33. Flow cytometry evaluation of the T-cell receptor Vbeta repertoire among human T-cell lymphotropic virus type-1 (HTLV-1) infected individuals: effect of interferon alpha therapy in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Saito M; Nose H; Usuku K; Sabouri AH; Matsuzaki T; Izumo S; Arimura K; Osame M
J Neurol Sci; 2006 Jul; 246(1-2):37-43. PubMed ID: 16545396
[TBL] [Abstract][Full Text] [Related]
34. [Pathophysiology, treatment and biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)].
Yamano Y; Sato T
Nihon Rinsho; 2013 May; 71(5):870-5. PubMed ID: 23777097
[TBL] [Abstract][Full Text] [Related]
35. Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP.
Grassi MF; Olavarria VN; Kruschewsky Rde A; Mascarenhas RE; Dourado I; Correia LC; de Castro-Costa CM; Galvão-Castro B
J Med Virol; 2011 Jul; 83(7):1269-74. PubMed ID: 21567429
[TBL] [Abstract][Full Text] [Related]
36. [Human T-Lymphotropic Virus Type I-Associated Myelopathy].
Nakamura T; Matsuo T
Brain Nerve; 2015 Jul; 67(7):845-58. PubMed ID: 26160813
[TBL] [Abstract][Full Text] [Related]
37. Increased human T lymphotropic virus type-1 (HTLV-1) proviral DNA in peripheral blood mononuclear cells and bronchoalveolar lavage cells from Japanese patients with HTLV-1-associated myelopathy.
Mita S; Sugimoto M; Nakamura M; Murakami T; Tokunaga M; Uyama E; Araki S
Am J Trop Med Hyg; 1993 Feb; 48(2):170-7. PubMed ID: 8447519
[TBL] [Abstract][Full Text] [Related]
38. Plasmatic proinflammatory chemokines levels are tricky markers to monitoring HTLV-1 carriers.
Chaves DG; Sales CC; de Cássia Gonçalves P; da Silva-Malta MC; Romanelli LC; Ribas JG; de Freitas Carneiro-Proietti AB; Martins ML
J Med Virol; 2016 Aug; 88(8):1438-47. PubMed ID: 26800845
[TBL] [Abstract][Full Text] [Related]
39. Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
Burbelo PD; Meoli E; Leahy HP; Graham J; Yao K; Oh U; Janik JE; Mahieux R; Kashanchi F; Iadarola MJ; Jacobson S
Retrovirology; 2008 Oct; 5():96. PubMed ID: 18937847
[TBL] [Abstract][Full Text] [Related]
40. Target epitopes of HTLV-1 recognized by class I MHC-restricted cytotoxic T lymphocytes in patients with myelopathy and spastic paraparesis and infected patients with autoimmune disorders.
Kozako T; Akimoto M; Toji S; White Y; Suzuki S; Arima T; Suruga Y; Matsushita K; Shimeno H; Soeda S; Kubota R; Izumo S; Uozumi K; Arima N
J Med Virol; 2011 Mar; 83(3):501-9. PubMed ID: 21264872
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
